Merck & Co., Inc. (NYSE: MRK) shares are trading higher by 3.4% at $84.18 after SVB Leerink maintained an Outperform rating on the stock and raised its price target from $101 to $104.
Bausch Health Companies Inc. (TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the company's July 28, 2022, press release, the U.S. District Court